IRIS
SORRENTINO, SABATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 909
AS - Asia 726
EU - Europa 405
SA - Sud America 148
AF - Africa 19
OC - Oceania 1
Totale 2.208
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 872
SG - Singapore 333
CN - Cina 176
IT - Italia 142
BR - Brasile 121
IN - India 101
DE - Germania 61
VN - Vietnam 58
SE - Svezia 42
GB - Regno Unito 39
NL - Olanda 35
FI - Finlandia 34
CA - Canada 23
HK - Hong Kong 17
ZA - Sudafrica 10
FR - Francia 9
MX - Messico 9
AR - Argentina 8
PL - Polonia 7
EC - Ecuador 6
IQ - Iraq 6
JP - Giappone 6
AT - Austria 5
BD - Bangladesh 5
CZ - Repubblica Ceca 5
CO - Colombia 4
ES - Italia 4
ID - Indonesia 4
RO - Romania 4
TR - Turchia 4
UZ - Uzbekistan 4
BE - Belgio 3
PY - Paraguay 3
RU - Federazione Russa 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
ET - Etiopia 2
KE - Kenya 2
LT - Lituania 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
VE - Venezuela 2
BB - Barbados 1
BH - Bahrain 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
KZ - Kazakistan 1
MA - Marocco 1
MY - Malesia 1
NR - Nauru 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TL - Timor Orientale 1
TN - Tunisia 1
Totale 2.208
Salva come PNG Salva come JPEG
Città #
Singapore 215
Chandler 103
Santa Clara 99
Bengaluru 93
Hefei 92
Dallas 71
Ashburn 57
Milan 50
Munich 42
Lawrence 34
Princeton 34
Chicago 25
London 24
Ho Chi Minh City 22
Helsinki 20
Wilmington 20
Los Angeles 18
São Paulo 18
Beijing 16
Hong Kong 16
New York 15
Turku 14
Hanoi 12
Rome 11
Assago 10
Brooklyn 10
Amsterdam 9
Boardman 9
Ottawa 9
Atlanta 8
Johannesburg 8
San Francisco 8
Shanghai 8
Stockholm 8
Des Moines 7
Catanzaro 6
Redmond 6
Warsaw 6
Charlotte 5
Hanover 5
Mexico City 5
Tokyo 5
Denver 4
Haiphong 4
Madison 4
Montreal 4
Olomouc 4
Tashkent 4
Ankara 3
Augusta 3
Bari 3
Boston 3
Buffalo 3
Campinas 3
Chennai 3
Erbil 3
Ferrara 3
Guangzhou 3
Porto Alegre 3
Portofino 3
Quito 3
Redwood City 3
Sorocaba 3
The Dalles 3
Topeka 3
Uberaba 3
Addis Ababa 2
Barbacena 2
Bocale 2
Brasília 2
Buriticupu 2
Cape Town 2
Columbus 2
Cosenza 2
Curitiba 2
Hasselt 2
Horia 2
Houston 2
Jeddah 2
Juneau 2
Macaé 2
Manchester 2
Miami 2
Montevideo 2
Nairobi 2
Naples 2
Nuremberg 2
Perugia 2
Ponta Grossa 2
Quảng Ngãi 2
Raleigh 2
San Jose 2
San Nicola Manfredi 2
Seattle 2
Secaucus 2
São José dos Campos 2
Terlizzi 2
Thái Nguyên 2
Trento 2
Verona 2
Totale 1.399
Salva come PNG Salva come JPEG
Nome #
Empagliflozin prevents doxorubicin-induced myocardial dysfunction 66
Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study. 61
B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis 48
Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery. 48
The duration of balloon inflation affects the luminal diameter of coronary segments after Bioresorbable Vascular Scaffolds deployment 46
Mir-16 Modulates Endothelial Dysfunction After Balloon Injury in a Rat Model of Chronic Peripheral Ischemia. 45
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials 44
Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician 44
Instantaneous wave-Free Ratio (iFR) and Gradient (iFG): new promising adenosine-independent alternative to fractional flow reserve. Preliminary results from the FORECAST Study. 43
Down-Regulation of miR-23/27/24 Clusters by TGF-beta 1 Signalling Induces Phenotypic Switching of Vascular Smooth Muscle Cells in vitro and in Response to Vascular Injury in vivo. 42
Indirect Comparison of the Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Network Meta-Analysis 42
Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis 41
Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report 39
The Role of Mir-16 on Endothelial Dysfunction in Rat with Atherosclerotic Diet with a Chronic Model of Femoral Artery Occlusion and Carotid Balloon Injury. 39
Predictors of outcomes in patients with mitral regurgitation undergoing percutaneous valve repair 39
Corrigendum to “miR-125a-5p Modulates Phenotypic Switch of Vascular Smooth Muscle Cells by Targeting ETS-1” (J. Mol. Biol. Jun 16 2017; 429(12):1817–1828) (S002228361730222X) (10.1016/j.jmb.2017.05.008) 39
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement 39
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention 38
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 37
MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts. 36
Single Versus Dual Antiplatelet Therapy Following TAVR: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 36
Incidence, Predictors, and Prognostic Impact of Neurologic Events After TAVR According to VARC-3 Criteria 35
Delayed sudden radial artery rupture after left transradial coronary catheterization: a case report. 35
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes 35
Mechanical heart valves between myths and new evidence: a systematic review and meta-analysis 34
Direct Oral Anticoagulants in Patients With Active Cancer 34
Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients 34
[Debate on dual pathway inhibition: Antiplatelet and anticoagulant therapies in patients undergoing percutaneous coronary intervention at high risk for recurrent ischemic events. Focus on anticoagulation-based strategies] 32
The instantaneous wave-Free Ratio (iFR) for evaluation of non culprit lesions in patients with Acute Coronary Syndrome and multivessel disease. 31
Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo 31
Acute expansion of nitinol-based self-expandable device in patients undergoing transfemoral aortic valve implantation 30
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis 30
Non-invasive myocardial work is reduced during transient acute coronary occlusion 30
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor. 29
Non-Invasive Myocardial Work in Patients with Severe Aortic Stenosis 29
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices 28
Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work 27
Risk of Bleeding in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement 26
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function 25
Reliability of Instantaneous Wave-Free Ratio (iFR) for the Evaluation of Left Main Coronary Artery Lesions 25
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials 24
Cellular and Molecular Mechanisms Underlying Tricuspid Valve Development and Disease 24
Stent Thrombosis After Percutaneous Coronary Intervention 23
Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal 23
Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions 23
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents 22
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation 21
Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials 21
Simultaneous Radial and Ipsilateral Ulnar Artery Compression versus Isolated Radial Artery Compression after Conventional Radial Access for Coronary Angiography and/or Intervention: A Systematic Review and Meta-Analysis 21
Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies 20
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention 20
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence 19
Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney Disease 19
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention 18
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis 18
The link between anemia and adverse outcomes in patients with acute coronary syndrome 17
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry 17
Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 17
Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 17
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 17
Rationale for Early Administration of PCSK9 Inhibitors in Acute Coronary Syndrome 17
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk 17
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial 17
Cerebral Embolic Protection During TAVR 16
Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies 16
Unmet Needs in TAVR: Conduction Disturbances and Management of Coronary Artery Disease 16
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial 15
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis 15
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention 15
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention 15
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 15
Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis 15
Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 14
Common Calcified Femoral Artery Rupture After Intravascular Lithotripsy for TAVR Implantation 14
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies 14
Paravalvular Leak 14
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention 14
null 14
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study 13
White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial 13
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction 13
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease 13
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention 13
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention 13
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry 13
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry) 13
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis 12
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age 12
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation 12
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 12
The Telecardiology Revolution: From Emergency Management to Daily Clinical Practice 11
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative 10
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 10
Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN‐TAVI registry 10
Effect of SGLT2 inhibitors on cardiac structure and function assessed by cardiac magnetic resonance: a systematic review and meta-analysis 6
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention 5
Effect of Transcatheter Aortic Valve Implantation on Non-Invasive Myocardial Work Parameters: A Systematic Review and Meta-Analysis 5
Artificial Intelligence in Cardiac Electrophysiology: A Clinically Oriented Review with Engineering Primers 4
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions 2
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry 2
Totale 2.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.371
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 10 4 5 6 5 3 2 6
2021/2022117 0 0 3 29 10 4 0 27 11 13 17 3
2022/2023352 74 12 40 12 45 28 3 26 52 21 30 9
2023/2024235 28 22 12 12 3 42 0 13 64 5 20 14
2024/2025835 97 35 34 22 61 137 43 16 79 15 118 178
2025/2026736 100 240 151 245 0 0 0 0 0 0 0 0
Totale 2.383